The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy
JACC: Heart Failure · 2025
DOI: 10.1016/j.jchf.2025.01.024 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Heart Failure, 2025. Verfasst von José M Larrañaga-Moreira und 28 weiteren Autor:innen. Beteiligte Einrichtung: Inherited Cardiac Disease Unit, Hospital Universitario de A Coruña (HUAC), Servizo Galego de Saúde (SERGAS), A Coruña, Spain; Instituto de Investigac…. Hauptthemen laut MEDLINE: Troponin T, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Variants in the cardiac troponin T gene (TNNT2) are a cause of hypertrophic cardiomyopathy (HCM) where mild TNNT2 structural phenotypes may be associated with sudden cardiac death. OBJECTIVES: This study aims to demonstrate a founder effect in A Coruña (Spain) and characterize the phenotype of the TNNT2 p.Asn271Ile variant in comparison with codon 92 variants, a hotspot previously associated with high risk. METHODS: Probands and relatives carrying the TNNT2 p.Asn271Ile variant were retrospectively recruited from a multicenter registry. Haplotype analysis was performed in 18 unrelated probands. The primary endpoint was a composite of malignant ventricular arrhythmia and end-stage heart failure. Clinical characteristics, penetrance, and outcomes were compared with codon 92 variants' carriers (p.Arg92Trp/Gln/Pro). RESULTS: The TNNT2 p.Asn271Ile cohort comprised 159 individuals (46 probands) from families mainly from the A Coruña region (33 of 48). Haplotype analysis revealed a common ancestor around 650 years ago. Late-onset HCM and incomplete age-related penetrance were observed (estimated median diagnosis age 60.1 years). Men were diagnosed 18.4 years before women (P < 0.001). The phenotype was predominantly mild, with a median left ventricular thickness of 17 mm; only 4.2% of patients reached the primary endpoint (3.2% malignant ventricular arrhythmia, 1.1% end-stage heart failure). Codon 92 variants' carriers (76 individuals, 28 probands) had a higher penetrance, being diagnosed 19.4 years earlier, and they exhibited a significantly worse prognosis (primary endpoint in 34.3%; P < 0.001). CONCLUSIONS: The p.Asn271Ile variant in the TNNT2 gene is associated with late onset HCM, with a low risk of adverse events. Variant-specific rather than gene-specific prognosis should be considered during sudden cardiac death risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inherited Cardiac Disease Unit, Hospital Universitario de A Coruña (HUAC), Servizo Galego de Saúde (SERGAS), A Coruña, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidade da Coruña (UDC), A Co…
- Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidade da Coruña (UDC), A Coruña, Spain; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain; Cardiology Department…
- Cardiology Department, Health in Code S.L, A Coruña, Spain.
- Inherited Cardiac Disease Unit, Hospital Universitario Son Llatzer and IdISBa, Palma de Mallorca, Spain.
- Inherited Cardiac Disease Unit, Virgen del Rocio University Hospital, Sevilla, Spain.
- Fundación Favaloro University Hospital, Buenos Aires, Argentina.
Zitieren
APA
Larrañaga-Moreira, J. M., Ochoa, J. P., Peteiro-Debén, R., Martín-Álvarez, E., Ripoll-Vera, T., Álvarez-Rubio, J., Peña-Peña, M. L., Llamas-Gómez, H., Fernández, A., Gallego-Delgado, M., Rodríguez-Serrano, A. I., Díez-López, C., Elliott, P. M., Palomino-Doza, J., Lorca, R., Limeres, J., Azevedo, O., Zorio, E., Martín-Dorado, E., …, & TNN Investigators (2025). The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2025.01.024
Vancouver
Larrañaga-Moreira JM, Ochoa JP, Peteiro-Debén R, Martín-Álvarez E, Ripoll-Vera T, Álvarez-Rubio J, et al. The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy. JACC: Heart Failure. 2025. doi:10.1016/j.jchf.2025.01.024
BibTeX
@article{LarraagaMoreira2025,
author = {Larrañaga-Moreira, José M and Ochoa, Juan P and Peteiro-Debén, Rosalía and Martín-Álvarez, Esteban and Ripoll-Vera, Tomás and Álvarez-Rubio, Jorge and Peña-Peña, María L and Llamas-Gómez, Helena and Fernández, Adrián and Gallego-Delgado, María and Rodríguez-Serrano, Ana I and Díez-López, Carles and Elliott, Perry M and Palomino-Doza, Julián and Lorca, Rebeca and Limeres, Javier and Azevedo, Olga and Zorio, Esther and Martín-Dorado, Ernesto and Méndez-Fernández, Irene and Franco-Gutiérrez, Raúl and de Frutos, Fernando and Escudero, Aida and Ruiz-Guerrero, Luis and Rodríguez-Vilela, Alejandro and Mazzanti, Andrea and McKenna, William J and Barriales-Villa, Roberto and TNN Investigators, TNN Investigators},
title = {The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy},
journal = {JACC: Heart Failure},
year = {2025},
doi = {10.1016/j.jchf.2025.01.024}
}
EUVIMED